HT110132

Eosin Y Solution, Alcoholic

Name: Eosin Y Solution, Alcoholic
Brand: SIGMA

Select a Size

All Photos(2)

About This Item

NACRES:

NA.47

UNSPSC Code:

41116124

form

solution

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

0.5 % (w/v) in acidified ethanol

application(s)

hematology
histology

storage temp.

room temp

Quality Level

500

Looking for similar products? Visit Product Comparison Guide

Related Categories

Clinical & Diagnostics

Hematology Stains

Histology Stains

Tissue Diagnostics

Application

General purpose cytoplasmic counterstain. Used with hematoxylin and eosin staining.

Other Notes

Certified Eosin Y, 0.5% (w/v) in acidified 90% ethanol

pictograms

GHS02,GHS05,GHS07

signalword

Danger

hcodes

H225,H290,H317,H319

pcodes

P210 - P233 - P234 - P280 - P303 + P361 + P353 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2 - Met. Corr. 1 - Skin Sens. 1

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

55.4 °F - closed cup

flash_point_c

13 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

0000472420

0000374405

0000330096

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.

Caitlin L Grzeskowiak et al.

Nature communications, 9(1), 2732-2732 (2018-07-18)

Genetic aberrations driving pro-oncogenic and pro-metastatic activity remain an elusive target in the quest of precision oncology. To identify such drivers, we use an animal model of KRAS-mutant lung adenocarcinoma to perform an in vivo functional screen of 217 genetic

Dynamics of extracellular matrix in ovarian follicles and corpora lutea of mice.

Helen F Irving-Rodgers et al.

Cell and tissue research, 339(3), 613-624 (2009-12-25)

Despite the mouse being an important laboratory species, little is known about changes in its extracellular matrix (ECM) during follicle and corpora lutea formation and regression. Follicle development was induced in mice (29 days of age/experimental day 0) by injections

Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.

Alexia Eliades et al.

The Journal of biological chemistry, 286(31), 27630-27638 (2011-06-15)

Lysyl oxidase (LOX), a matrix cross-linking protein, is known to be selectively expressed and to enhance a fibrotic phenotype. A recent study of ours showed that LOX oxidizes the PDGF receptor-β (PDGFR-β), leading to amplified downstream signaling. Here, we examined

Soluble Milk Proteins Improve Muscle Mass Recovery after Immobilization-Induced Muscle Atrophy in Old Rats but Do not Improve Muscle Functional Property Restoration.

J Verney et al.

The journal of nutrition, health & aging, 21(10), 1133-1141 (2017-12-01)

Effect of 3 different dairy protein sources on the recovery of muscle function after limb immobilization in old rats. Longitudinal animal study. Institut National de la Recherche Agronomique (INRA). The study took part in a laboratory setting. Old rats were

Epidermal differentiation and loss of clonal growth potential of human limbal basal epithelial progenitor cells during intrastromal invasion.

Ek Kia Tan et al.

Investigative ophthalmology & visual science, 52(7), 4534-4545 (2011-04-30)

Intrastromal invasion by limbal basal epithelial progenitor cells in explant cultures is associated with epithelial-mesenchymal transition. It remains unclear whether intrastromal invasion is contingent on culturing conditions and whether invaded cells retain their progenitor status and original lineage. Human limbal

View All Related Papers